A uniform technique of one-stage factor VIII:C assay in cryoprecipitate and its concentrates. Part II (according to the results obtained by the group of the "Hemostasis Pathology Commission)
Elykomov, V.A.; Tsalikhin, A.D.
Gematologiia i Transfuziologiia 36(11): 31-33
1991
ISSN/ISBN: 0234-5730 PMID: 1800237 Document Number: 372150
Document emailed within 1 workday
Related Documents
Lee, C.A.; Owens, D.; Bray, G.; Giangrande, P.; Collins, P.; Hay, C.; Gomperts, E.; Schroth, P.; Barrowcliffe, T. 1999: Pharmacokinetics of recombinant factor VIIi (recombinate) using one-stage clotting and chromogenic factor VIIi assay Thrombosis and Haemostasis 82(6): 1644-1647Rosén, S. 2001: A rebuttal: Issues with the assay of factor VIII activity in plasma and factor VII concentrates Thrombosis and Haemostasis 86(4): 1132-1133
Allersma, D.P.; Smid, W.M.; van der Does, J.A.; van der Meer, J.; Briët, E. 1996: Effects of chronic factor VIII substitution on immune parameters in HIV seronegative haemophiliacs: a comparison between cryoprecipitate and factor VIII concentrate Thrombosis and Haemostasis 75(2): 261-266
Brown, J.E.; Carton, C.L.; Hougie, C. 1981: The effect of naturally occurring antibodies to factor VIIi on an immunoradiometric assay for factor VIIi coagulant antigen. Observation on a cross-reacting material-positive (CRM+) hemophiliac with a factor VIIi inhibit Journal of Laboratory and Clinical Medicine 97(1): 65-71
Escolar, G.; Carretero, M.; Magallón, M.; Quintana, M.; Arnau, C.; Castillo, R.; Aznar-Salatti, J. 1998: von Willebrand factor contained in factor VIII concentrates of different purities supports platelet adhesion in blood samples from a heterogeneous group of patients with von Willebrand disease Haematologica 83(11): 1009-1014
Kunst, V.A.; Nováková, I.R.; Haanen, C. 1989: Cryoprecipitate should have preference over factor VIII concentrate in the treatment of patients with hemophilia A Nederlands Tijdschrift Voor Geneeskunde 133(23): 1163-1166
Mazurier, C.; Meyer, D. 1996: Factor VIII binding assay of von Willebrand factor and the diagnosis of type 2N von Willebrand disease--results of an international survey. On behalf of the Subcommittee on von Willebrand Factor of the Scientific and Standardization Committee of the ISTH Thrombosis and Haemostasis 76(2): 270-274
Allain, J.P. 1972: Study of the "in vivo" activity of factor VIIi or factor IX after injection of several concentrates: practical applications Nouvelle Revue Francaise d'Hematologie 12(2): 241-249
Piedras, J.; Sánchez-Montero, P.E.; Herrera, F.M.; Córdova, M.S.; Sánchez-Medal, L. 1993: Effect of plasma freezing temperature, anticoagulant and time of storage on factor VIII:C activity in cryoprecipitate Archives of Medical Research 24(1): 23-26
Vicente, V. 1989: Plasma concentrates of factor VIII. Where are we? Sangre 34(1): 1-3
Yoshioka, A.; Shima, M.; Nishino, M.; Yoshikawa, N.; Fukui, H. 1987: In vitro characterization of various factor VIII concentrates Arzneimittel-Forschung 37(7): 753-756
Klarmann, D.; Kreuz, W.; Auerswald, G.; Auberger, K.; Rabenau, H.; Gürtler, L.; Roggendorf, M. 1995: Hepatitis C and pasteurised factor VIIi and IX concentrates Thrombosis and Haemostasis 73(4): 736-737
Mahasandana, C.; Suvatte, V.; Püng-amritt, P.; Tuchinda, S. 1979: Von Willebrand's disease: studies of platelet functions, factor VIII procoagulant activity (F VIII C) and factor VIII-related antigen (F VIII RAg) in three families Southeast Asian Journal of Tropical Medicine and Public Health 10(2): 243-247
Kessler, C.M.; Ludlam, C.A. 1993: The treatment of acquired factor VIII inhibitors: worldwide experience with porcine factor VIII concentrate. International Acquired Hemophilia Study Group Seminars in Hematology 30(2 Suppl. 1): 22-27
Kröniger, A.; Kumpe, A.; Wormsbächer, W.; Herchenhahn, B. 1982: Factor VIIi concentrates. Problems and protein chemistry characterization Die Medizinische Welt 33(28): 1027-1033
Mikaelsson, M.; Oswaldsson, U.; Nilsson, I.M. 1994: Potency and in vivo recovery of high purity factor VIII concentrates Thrombosis and Haemostasis 72(1): 160-161
Rodríguez Bueno, S.; Montoro Ronsano, J.B.; Martínez Sánchez, B.; Altisent Roca, C.; Tusell Puigvert, J.M. 1991: The administration of factor VIIi concentrates to hemophiliacs by continuous perfusion pump Medicina Clinica 96(10): 364-366
Laurian, Y.; Dussaix, E.; Parquet, A.; Chalvon-Demersay, A.; d'Oiron, R.; Tchernia, G. 1994: Transmission of human parvovirus B19 by plasma derived factor VIIi concentrates Nouvelle Revue Francaise d'Hematologie 36(6): 449-453
Kasper, C.K.; Kim, H.C.; Gomperts, E.D.; Smith, K.J.; Salzman, P.M.; Tipping, D.; Miller, R.; Montgomery, R.M. 1991: In vivo recovery and survival of monoclonal-antibody-purified factor VIII concentrates Thrombosis and Haemostasis 66(6): 730-733
Eich, S.; Kusch, M.; Grundmann, C.; Hanker, C.; Seitz, R.; König, H. 2003: Factor VIII determination in patient's plasma and concentrates: a novel test equally suited for both matrices Blood Coagulation and Fibrinolysis: An International Journal in Haemostasis and Thrombosis 14(4): 347-353